Hap Trading, LLC Bridge Bio Pharma, Inc. Call Options Transaction History

Hap Trading, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$23.0 - $31.04 $1.15 Million - $1.55 Million	-50,000 Reduced 44.44%	62,500 $15.6 Million
Q1 2024 May 13, 2024	BUY	$27.35 - $40.45 $3.08 Million - $4.55 Million	112,500 New	112,500 $68.4 Million
Q2 2023 Aug 11, 2023	BUY	$13.29 - $18.01 $5.81 Million - $7.87 Million	437,200 New	437,200 $7.52 Million
Q2 2022 Aug 12, 2022	SELL	$5.21 - $12.14 $153,695 - $358,130	-29,500 Reduced 67.51%	14,200 $17,000
Q1 2022 May 12, 2022	SELL	$7.34 - $17.16 $3.28 Million - $7.67 Million	-446,900 Reduced 91.09%	43,700 $45,000
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $5.47 Million - $25.7 Million	480,600 Added 4806.0%	490,600 $43,000
Q2 2021 Aug 11, 2021	BUY	$46.47 - $63.93 $464,700 - $639,300	10,000 New	10,000 $104,000
Q3 2020 Nov 13, 2020	SELL	$27.2 - $42.19 $3.59 Million - $5.57 Million	-132,100 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$22.22 - $35.69 $706,596 - $1.13 Million	31,800 Added 31.7%	132,100 $294,000
Q1 2020 May 08, 2020	BUY	$16.11 - $36.23 $1.62 Million - $3.63 Million	100,300 New	100,300 $359,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.92B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.